Skip to main content
Sunday, November 15, 2026Nov 15

Pfizer tops Street 1Q forecasts on higher sales, lower taxes

FILE - In this Monday, Nov. 23, 2015, file photo, a man enters Pfizer's world headquarters, in New York. Pfizer reports financial results on Tuesday, May 3, 2016. (AP Photo/Mark Lennihan, File)
FILE - In this Monday, Nov. 23, 2015, file photo, a man enters Pfizer's world headquarters, in New York. Pfizer reports financial results on Tuesday, May 3, 2016. (AP Photo/Mark Lennihan, File)

Pfizer easily beat Wall Street expectations for the first quarter as the biggest U.S. drugmaker’s net income jumped 27 percent due to higher sales and a lower tax bill. The company raised its 2016 financial forecasts, citing its strong operational performance in the quarter and an improved business outlook.

Its shares surged almost 3 percent in premarket trading.

Just four weeks after dropping its record $160 billion deal to buy fellow drugmaker Allergan Plc and move its headquarters on paper to Ireland to reduce its taxes, New York-based Pfizer Inc. on Tuesday reported first-quarter net income of $3.02 billion, or 49 cents per share. That was up from $2.38 billion, or 38 cents per share, in 2015’s first quarter.

Excluding one-time items, adjusted profit in the latest quarter was 67 cents per share, 12 cents better that the 55 cents expected by analysts surveyed by Zacks Investment Research.

The maker of Viagra and pain treatment Lyrica posted revenue of $13.01 billion in the period, up 20 percent and well above the $11.97 billion analysts expected.